Sponsored Content | Webinar | Radiation Therapy| October 13, 2017

WEBINAR: Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation

Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation Therapy, MRI guided RT.

The webinar "Pancreatic Cancer Outcome Highlights via On-table Adaptive MR-guided Radiation" was presented by Parag Parikh, BSE, M.D., associate professor of radiation oncology and biomedical engineering at Washington University in St. Louis, and Percy Lee, M.D., associate professor and vice chair of education for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. They will share their ongoing experience in using MR-guided radiation therapy to treat pancreatic cancer.

The webinar took place Tuesday, Oct. 24, 2017.

View the archived webinar.

This presentation includes highlights of significant outcomes and treatment protocols currently used with their patients. The webinar will compliment the presenters' poster published at ASTRO17, “Higher Maximum Biologic Effective Dose Utilizing Adaptive MRI Guided Radiation Therapy Improves Survival of Inoperable Pancreatic Cancer Patients," which provided a retrospective review of 42 locally-advanced pancreatic cancer patients treated at four institutions:

- Washington University and Siteman Cancer Center at Barnes-Jewish Hospital, St. Louis

- University of California, Los Angeles Health System and Jonsson Comprehensive Cancer Center

- University of Wisconsin Carbone Cancer Center in Madison

- VU University Medical Center in Amsterdam, Netherlands

The study found that stereotactic dosing regimens guided by MR imaging using the MRIdian system and daily online adaptation had led to significantly prolonged patient survival and resulted in favorably low toxicity.

 

Presenters:

Percy Lee, M.D.
Associate Professor Vice Chair, Education Director, Stereotactic Body Radiation Therapy Program
David Geffen School of Medicine at UCLA , UCLA Jonsson Comprehensive Cancer Center

Dr. Lee is an associate professor and vice chair of education for the Department of Radiation Oncology at the David Geffen School of Medicine at UCLA and the UCLA Jonsson Comprehensive Cancer Center. Lee is the clinical director of the stereotactic body radiation therapy (SBRT) program and the chief of service for the thoracic and GI radiation cncology programs in the department. He also serves as the residency training program drector as well as the director for the medical student clerkship. Lee attended the Johns Hopkins University and graduated with the highest honors majoring in biomedical engineering with a concentration in chemical engineering. He attended Harvard Medical School and the Harvard-MIT Health Science and Technology Program where he received his M.D., and graduated magna cum laude. At Harvard, he was also a Howard Hughes Medical Institute fellow. He interned at the Massachusetts General Hospital and received specialty training in radiation oncology from Stanford University School of Medicine.

 

Parag Parikh, BSE, M.D
BSE Associate Professor of Radiation Oncology
Washington University School of Medicine in St. Louis 

Parag Parikh, BSE, M.D. is an associate professor of radiation oncology and biomedical engineering at Washington University in St. Louis. He serves as the chief of the gastrointestinal radiation oncology service at Washington University School of Medicine – Barnes Jewish Hospital - Siteman Cancer Center. He sees 400 new patients with pancreatic, liver, rectal and anal cancers per year. He has been routinely using MR-guided radiation therapy for three years, and will be coordinating a multicenter trial with UCLA and other institutions that looks at high dose radiation delivered with MR-guided radiation therapy to treat pancreatic cancer.

 

About ViewRay

ViewRay Inc. (Nasdaq: VRAY) designs, manufactures and markets the MRIdian radiation therapy system. MRIdian integrates MRI technology, radiation delivery and proprietary software to locate, target and track the position and shape of soft-tissue tumors during radiation. ViewRay believes this combination of enhanced visualization and accuracy will significantly improve outcomes for patients.

ViewRay and MRIdian are registered trademarks of ViewRay Inc.

 

View the archived webinar.

Related Content

RaySearch Releases New Version of RayCare OIS
Technology | Oncology Information Management Systems (OIMS) | July 13, 2018
RaySearch has released RayCare 2A, the latest version of its flagship oncology information system (OIS). RayCare is...
Lack of Insurance Coverage Delaying Proton Therapy Clinical Trials
News | Proton Therapy | July 12, 2018
Randomized clinical trials are the gold standard of cancer research and can shed light on whether innovative, new...
Bruce Power Joins Forces With ITM to Supply Lutetium-177 for Cancer Therapy
News | Radiation Therapy | July 11, 2018
Canadian nuclear power company Bruce Power and German-based Isotope Technologies Garching (ITG) signed an agreement to...
MedStar Georgetown University Hospital Now Clinical With RayStation and Hyperscan
News | Treatment Planning | July 05, 2018
MedStar Georgetown University Hospital in Washington D.C., has begun patient treatments using the RayStation treatment...
Northern Centre for Cancer Care (NCCC)

Northern Centre for Cancer Care (NCCC).

Sponsored Content | Case Study | Radiation Therapy | July 05, 2018
Established in 2009, Northern Centre for Cancer Care (NCCC) is the largest center of its kind in the north of England....
Feature | Proton Therapy | July 03, 2018 | By Jeff Zagoudis
The Alliance for Proton Therapy Access (APTA) released a national report in late May revealing the heavy emotional and...
Researcher Investigates Eliminating Radiation for HER2-Positive Breast Cancer
News | Radiation Therapy | July 02, 2018
Researchers at The University of Kansas Cancer Center have launched a clinical trial that eliminates radiation from the...
New Prostate Cancer Radiotherapy Technique Aims to Preserve Sexual Function
News | Radiation Therapy | June 18, 2018
A multicenter clinical trial being led by UT Southwestern physicians is testing a technique for sparing nerve bundles...
Elekta Unity High-Field MR-Linac Receives CE Mark
News | Image Guided Radiation Therapy (IGRT) | June 18, 2018
Elekta announced that its Elekta Unity magnetic resonance radiation therapy (MR/RT) system has received CE mark,...
Washington University in St. Louis Begins Clinical Treatments With ViewRay MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | June 14, 2018
June 14, 2018 — The Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in S
Overlay Init